Tricks and Tips
Showing posts with label Healthcare. Show all posts
Showing posts with label Healthcare. Show all posts

Tuesday, 13 February 2018

Global Immunology Market Is Estimated To Grow At A CAGR of 4.57% During the Period 2018-2022

Global Immunology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

About Immunology
The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules.
Different pathways regulate various immune cells for distinguishing body’s healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body’s defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential.
Sometimes, the continuously modifying immune system reacts against the body’s cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.
The global Immunology Market to grow at a CAGR of 4.57% during the forecasted period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global immunology market for 2018-2022. To calculate the market size, the report considers the revenue generated from the immunology.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Key Vendors
• AbbVie
• Amgen
• F. Hoffmann-La Roche
• Johnson & Johnson
Market Driver
• Growing cases of infectious diseases
• For a full, detailed list, view our report
Market Trend
• Significant pipeline
• For a full, detailed list, view our report
Key questions answered in this report
  1. What will the market size be in 2022 and what will the growth rate be?
  2. What are the key market trends?
  3. What is driving this market?
  4. What are the challenges to market growth?
  5. Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
For More Details Visit @ Hexa Reports
Posted by No comments:
Labels:

Tuesday, 6 February 2018

Stem Cell Banking Market Research Methodology and Competitive Analysis by 2018-2022

Global Stem Cell Banking Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The global stem cell banking market is a closely related market to the global regenerative medicine market. Regenerative medicine is a key branch of modern medicine, which has emerged as a combination of tissue engineering and molecular biology. Regenerative medicine aims to re-engineer human cells, tissues, or organs, which can replace or restore the normal functioning of impaired cells, tissues; or organs.


The Global Stem Cell Banking Market to grow at a CAGR of 12.76% during the period 2018-2022.

About this report
The report covers the present scenario and the growth prospects of the global stem cell banking market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Key vendors
• AMAG Pharmaceuticals
• Cordlife
• Cryo-Cell International
• Esperite


Other prominent vendors
• Cellular Dynamics International
• China Cord Blood Corporation
• Cordvida
• Cryo Stemcell

Market driver
• Growing prevalence of cancer
• For a full, detailed list, view our report

Market trend
• Growing acceptance of stem cell therapies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

For More Details Visit @ Hexa Reports

Posted by No comments:
Labels:

Heart Failure Drugs Market Trends, Framework and Key Vendor Analysis by 2018-2022

Global Heart Failure Drugs Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period.

Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure
.

The Global Heart Failure Drugs Market to grow at a CAGR of 10.46% during the period 2018-2022.

About this report
The report covers the present scenario and the growth prospects of the global heart failure drugs market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of heart failure drugs.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
Key vendors
  • Amgen
  • AstraZeneca
  • Bayer
  • Novartis

Other prominent vendors
  • Gilead
  • GlaxoSmithKline
  • Pfizer
  • Teva Pharmaceutical industries
Market driver
  • Rising geriatric population
  • For a full, detailed list, view our report
Market trend
  • Investment inclination toward developing countries
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

For More Details Visit @ Hexa Reports

Posted by No comments:
Labels:

Friday, 19 January 2018

Hospital Artificial Intelligence Market Is Forecasted To Reach USD 50 Billion By 2023

Artificial Intelligence Market Forecasts
Hospital Artificial Intelligence Market shipments at $19 billion in 2016 are forecast to reach $50 billion dollars, worldwide 2023. These represent a very specialized type of analytics systems able to address a wide range of issues that can be newly managed with digitization. Steady growth is anticipated because the AI units are offering breakthrough treatments and diagnostic capabilities.
Hospital Artificial Intelligence Market
Hospital Artificial Intelligence
Hospital care management can leverage augmented intelligence. Artificial intelligence is useful for providing highly tailored insights about individual patients or to work across an entire population. Artificial intelligence is useful for helping providers effectively address healthcare delivery.
The intersection of healthcare and artificial intelligence represents a market opportunity. New strategies are being developed by companies to bring A.I. to healthcare. The business challenges around those efforts are being addressed collectively in partnerships and in forums to bring the technology into the market. Artificial intelligence has an impact on patients, doctors, hospitals, clinical facilities, and the healthcare industry overall.
The ability of an intelligent system to learn from data without upfront human intervention brings significant change to the healthcare delivery system. It relies on the use of unsupervised and semi-supervised machine learning techniques. Segmentation, dimensionality reduction, anomaly detection and pattern recognition are replacing supervised manual techniques for diagnosis and care delivery.
Major factors driving the market for artificial intelligence in hospitals include its ability to provide better diagnostic accuracy under a variety of testing conditions. The worldwide aging population creates demand for increased accuracy of early diagnosis. An increase in the number of people with end stage diabetes, cancer, and severe respiratory diseases creates need for advanced medical diagnostic capabilities that work earlier in the evolution of disease, creating the ability to implement therapies that are lifesaving.
“Partners HealthCare and GE Healthcare are launching a 10-year partnership to bring artificial intelligence into every area of hospital operations. IBM brings Watson to the hospital AI landscape in hospitals. “Progress is demonstrated by the health care AI launch to the Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science (Partners).
Multidisciplinary teams from Partners and GE Healthcare have worked to develop applications for AI in every step of the patient journey from the moment they are admitted to the hospital. “Long-term, the goal is to develop applications that improve the way illnesses are diagnosed, change how treatment is developed, decrease unnecessary biopsies, streamline clinical workflows, and increase the amount of time clinicians spend with patients.”
For More Details Visit @ Hexa Reports
Posted by No comments:
Labels:

Thursday, 18 January 2018

Drug of Abuse Testing Services Market Growth Prospect, Value Chain Analysis and Forecast by 2014-2025

The Global Drug of Abuse Testing Services Market is expected to reach USD 2.9 billion by 2025, according to a new report by Hexa Reports. Increase in demand for therapy for substance abuse is one of the crucial factors anticipated to boost the market. According to World Drug Report 2016, annually, treatments for drug abuse are accessible to only 17% of the total drug abusers. In North American, Eastern & Southeastern Europe, and Asia, opioid is one of the major drugs of concern.


According to World Drug Report 2016, 1 in every 20 people aged 15 to 64 consumed at least one drug in 2014. More than 29 million people who abuse drugs are estimated to suffer from drug-related disorders. There are 12 million people that abuse drugs, out of whom 14% are suffering from HIV. Cannabis and amphetamine are some of the highly abused drugs globally. Approximately 183 million people used cannabis in 2014. Stringent regulations for drug abuse testing at workplaces, such as Omnibus Transportation Employee Testing Act of 1991, etc., are expected to increase demand for screening kits over the forecast period.


Morbidity and mortality due to drug abuse are rising globally. One in every 4 deaths is attributed to tobacco, alcohol, and illicit drug consumption. The overdose of opioids results in adverse and serious health conditions. In the U.S., the nonmedical use of prescription opioids has considerably increased. According to statistics reported by National Institute of Drug Abuse, overdose of opioids results in more than 90 deaths every day in the U.S. The rise in prevalence of comorbidities associated with substance abuse, such as HIV and hepatitis C, have resulted in increase in demand for screening procedures. Furthermore, increase in the number of government initiatives to control illicit drugs and alcohol usage and rise in number of treatment alternatives are also driving the market.

Further key findings from the report suggest:
• The global drug of abuse testing services market size was estimated at USD 1,465.4 million in 2016 and is expected to grow at a CAGR of 8.1% from 2017 to 2025
• Cannabis emerged as the largest drug type segment and the opioids segment is anticipated to witness fastest growth over the next 8 years
• The North America region accounted for the largest market share in 2016 due to increased usage of medical marijuana, increased usage of investigational testing, and rise in number of toxicology laboratories.
• Asia Pacific is anticipated to witness lucrative growth over the next decade due to increase in alcohol consumption and related disorders in this region
• The market is highly consolidated in the U.S., with Laboratory Corporation of America Holdings; Alere; United States Drug Testing Laboratories, Inc. (USDTL); Quest Diagnostics, Inc. holding 85% market share.


Table of Contents
• Chapter 1 Research Methodology
• Chapter 2 Executive Summary
• Chapter 3 Drug of Abuse Testing Services Market Variables, Trends & Scope
• Chapter 4 Drug of Abuse Testing Services Market: Product Estimates & Trend Analysis
• Chapter 5 Drug of Abuse Testing Services Market: Regional Estimates & Trend Analysis, by Drug Type
• Chapter 6 Competitive Landscape

For More Details Visit @ Hexa Reports

Posted by No comments:
Labels:

ECG Equipment and Management System Market Report Guidance for Industry Review and Market Analysis to 2014-2025

The Global ECG Equipment and Management Market is expected to reach USD 7.63 million by 2025, according to a new report by Hexa Reports. Increase in geriatric population across the world coupled with rise in cardiac diseases are likely to drive the market during the forecast period.


Furthermore, increase in investment by various market players and government agencies for development and commercialization of various sensitive and easy-to-use equipment is likely to drive market growth. For instance, in April 2017, CardioComm Solutions, Inc. entered into a conglomerate with CareSpan USA Inc. to incorporate CardioComm's cloud-based ECG analysis tools into CareSpan's Virtual Clinic. This would help in remote analysis of 1, 3, and 12 lead ECG data for online patient care.


In September 2017, the U.S. FDA approved app-driven, easy-to-clean, and fully reusable ECG device manufactured by NimbleHeart. The device wraps around user's torso and is used without electrolytic gels and adhesive. Hence, the device can be cleaned easily, thereby, making the product ideal for multipatient use.

Further Key Findings From the Report Suggest:
• Rising incidence of cardiac diseases and growing geriatric population are expected to propel the growth of the market with a CAGR of 5.8% from 2017 to 2025
• Resting ECG system segment accounted for the highest share of the market and is expected to witness significant growth during the forecast period. This can be attributed to the availability of several commercial products and improved clinical accuracy due to advanced data analysis tools to detect heart related problems.
• Management system segment is witnessed to be the fastest growing segment in the forecast period owing to introduction of innovative products such as mobile access to waveforms, ease of use, and increased efficiency.
• Geographically, North America was the major contributor in the ECG equipment and management market in 2016. It is anticipated to maintain its dominance during the forecast period due to demand for portable monitoring & diagnostic devices, adoption of new technologies, and product launches.
• The market in Asia Pacific is likely to witness significant growth over the next decade owing to increasing investments and entry of key market players in the region, and growing healthcare expenditure and disposable income, in major markets, such as Japan and China.
• Some of the key players are BioTelemetry, Inc.; Compumed Inc.; GE Healthcare; Mindray Medical; Hill Rom; NIHON KOHDEN CORPORATION; Philips Healthcare; Schiller AG; Spacelabs Healthcare; Welch Allyn; CardioComm Solutions, Inc.; McKesson Corporation; Device Technologies; and Meditech.


Table of Contents
• Chapter 1. Methodology and Scope
• Chapter 2. Executive Summary
• Chapter 3. ECG Equipment and Management System Industry Outlook
• Chapter 4. ECG Equipment and Management System Market: Type Outlook
• Chapter 5. ECG Equipment and Management System Market: End-User Outlook
• Chapter 6. ECG Equipment and Management System Market: Regional Outlook
• Chapter 7. Competitive Landscape
• Chapter 8. Company Profiles

For More Details Visit @ Hexa Reports

Posted by No comments:
Labels:

Wednesday, 17 January 2018

Medical Aesthetics Market Industry Outlook, Growth Prospects and Key Opportunities by 2018-2022

Global Medical Aesthetics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The global medical aesthetics market is a contributing segment of the global medical devices market. From a top-down perspective, it has analysed the medical devices market as a related market to set the context, in which the global medical aesthetics market will be analysed. The medical devices market comprises all the instruments, machines, implants, or in vitro reagents, which are used in diagnosis, mitigation, treatment, or prevention of any disease. It is a highly diversified market in terms of products and technologies involved.

Regulatory organizations such as the US Food and Drug Administration (FDA) assess medical devices as per a pre-defined medical device development tool (MDDT) program. The MDDT is used to qualify tools that medical device manufacturers or sponsors can use in the development and evaluation of the safety of medical devices.


The Global Medical Aesthetics Market to grow at a CAGR of 7.29% during the period 2018-2022.

About this report
The report covers the present scenario and the growth prospects of the global medical aesthetics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of medical aesthetics.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
Key vendors
  • Allergan
  • Dentsply Sirona
  • Galderma
  • Johnson & Johnson

Other prominent vendors
  • 3M
  • ADIN Dental Implant Systems
  • Alma Lasers
  • BioHorizons
Market driver
  • Rapid advantages in technology
  • For a full, detailed list, view our report
Market trend
  • Increasing global awareness about medical aesthetics
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

For More Details Visit @ Hexa Reports

Visit our Blog: https://marketresearchreportsinsights.wordpress.com/
Posted by No comments:
Labels:

Influenza Vaccine Market Business Opportunities, Current Trends & Analytical Overview by 2018-2022

Global Influenza Vaccine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases.

Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market growth include the need for annual vaccination and government initiatives to improve awareness about vaccination.


The Global Influenza Vaccine Market to grow at a CAGR of 7.23% during the period 2018-2022.

About this report
The report covers the present scenario and the growth prospects of the global influenza vaccine market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of influenza vaccine.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
Key vendors
  • AstraZeneca
  • CSL
  • GlaxoSmithKline
  • Sanofi

Other prominent vendors
  • Altimmune
  • BionVax
  • FluGen
  • FOLIA BIOTECH
Market driver
  • Rising awareness about influenza vaccination
  • For a full, detailed list, view our report
Market trend
  • Development of strong pipeline
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

For More Details Visit @ Hexa Reports

Visit our Blog: https://marketresearchreportsinsights.wordpress.com/
Posted by No comments:
Labels:
Subscribe to: Comments (Atom)